Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Celgene Corporation Clinical Trials Information presented on Clinical Trials Search isn't meant to be a substitute for certified medical advice, visits or professional assistance with a genuine dr.. We are not docs. Always confer with your mD about Celgene Corporation clinical studies. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Celgene Corporation Clinical research trials and Celgene Corporation health trials occur in many of localities across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectivity of new drugs. The purpose of the studies / undertakings is to resolve specific human health questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies like Celgene Corporation to locate cures for all forms of conditions. Celgene Corporation Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment options before they are available to the general public. Most times the test subjects receive professional assistance for free of charge, and every now and again they are compensated for their time. Sometimes there is a cost for a Celgene Corporation clinical trial. Test subjects oftentimes recieve the finest healthcare available for their condition. Hazards are a reality, nonetheless, and could include more or frequent dr. trips, health risks (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally regulated with exacting guidelines to protect clinical trials patients.

Home > "C" Clinical Trials Sponsors > Celgene Corporation Clinical Trials

Celgene Corporation Clinical Trials



A Multicenter, open-label study to evaluate the preliminary safety and efficacy of CC-5013 in the treatment of Complex Regional Pain Syndrome (CRPS)
Condition: celgene_corporation_clinical_trials.html
Celgene Corporation

A Phase II Study of Continuous versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple Myeloma
Condition: celgene_corporation_clinical_trials.html
Celgene Corporation

A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome
Condition: celgene_corporation_clinical_trials.html
Celgene Corporation

A study to access the safety/efficacy of thalidomide in the treatment of anemia in patients with Myelodysplastic Syndromes
Condition: celgene_corporation_clinical_trials.html
Celgene Corporation

CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects with Multiple Myeloma
Condition: celgene_corporation_clinical_trials.html
Celgene Corporation

CDC-501 therapy in relapsed or refractory multiple myeloma
Condition: celgene_corporation_clinical_trials.html
Celgene Corporation

Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome
Condition: celgene_corporation_clinical_trials.html
Celgene Corporation

D-MPH in the treatment of fatigue and neurobehavioral function related to chemotherapy in adult cancer patients
Condition: celgene_corporation_clinical_trials.html
Celgene Corporation

Efficacy and safety study of CC-5013 monotherapy in subjects with myelodysplastic syndromes
Condition: celgene_corporation_clinical_trials.html
Celgene Corporation

Phase 1 Study OF CDC-501 in Patients with Solid Tumors
Condition: celgene_corporation_clinical_trials.html
Celgene Corporation

Phase I trial of CC-8490 for the treatment of subjects with recurrent/refractory high-grade gliomas
Condition: celgene_corporation_clinical_trials.html
Celgene Corporation

Safety and efficacy of CC-5013 monotherapy in subjects with myelodysplastic syndromes associated with a del (5q) cytogenetic abnormality
Condition: celgene_corporation_clinical_trials.html
Celgene Corporation

Safety and efficacy of single-agent CC-5013 in subjects with relapsed and refractory multiple myeloma
Condition: celgene_corporation_clinical_trials.html
Celgene Corporation

Study of Combination Thalidomide Plus Glucocorticoid Therapy Versus Glucocorticoid Therapy Alone as Induction Therapy for Previously Untreated Subjects with Multiple Myeloma
Condition: celgene_corporation_clinical_trials.html
Celgene Corporation

Study of the Safety and Efficacy of CC-5013 Treatment For Patients with Myelodysplastic Syndrome
Condition: celgene_corporation_clinical_trials.html
Celgene Corporation

Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects with Metastatic Malignant Melanoma.
Condition: celgene_corporation_clinical_trials.html
Celgene Corporation

Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects with Metastatic Malignant Melanoma
Condition: celgene_corporation_clinical_trials.html
Celgene Corporation

Study to Determine the Safety and Preliminary Efficacy of CC-1088 in the Treatment of Myelodysplastic Syndromes
Condition: celgene_corporation_clinical_trials.html
Celgene Corporation



Celgene Corporation Clinical Trials
Modify your Search

Other "C" Clinical Trials Sponsors:

California Cancer Consortium
Cambridge Translational Cancer Research
Cancer And Leukemia Group B
Cancer Biotherapy Research Group
Cancer Institute Of New Jersey
Cancer Research Campaign Clinical Trials Centre
Cancer Research Institute Of Contra Costa
Cancer Research Uk
Cancer Research Uk And University College London Cancer Trials Unit
Cancer Research Uk At The University Of Cambridge
Cancer Research Uk Clinical Groups At Guy's King's & St. Thomas' Hospitals
Cancer Research Uk Clinical Trials Unit At The University Of Glasgow
Cancer Research Uk Medical Oncology Unit At Churchill Hospital & Weatherall Institute Of Molecular Medicine - Oxford
Cancervax Corporation
Cardio Vascular Genetic Engineering
Cardiome Pharma
Cedars-Sinai Medical Center
Celgene Corporation
Cell Pathways
Cell Therapeutics
Celsion
Centaur Pharmaceuticals
Center For Medicinal Cannabis Research
Center For Molecular Medicine
Centers For Disease Control And Prevention
Centocor
Centocor, Inc & Eli Lilly And Co.
Centre Paul Strauss
Centro Di Riferimento Oncologico - Aviano
Centro Oncologico De Excelencia
Cephalon
Chao Family Comprehensive Cancer Center
Charles A Dana Foundation
Chemgenex Therapeutics
Children's Hospital And Medical Center - Seattle
Children's Hospital Of Philadelphia
Children's Oncology Group
Chimeric Therapies
Chiron Corporation
Christie Hospital N.h.s. Trust
Chugai Pharma Usa
Cleveland Clinic Cancer Center
Cleveland Clinic Foundation Hospital
Clinical Solutions
Coley Pharmaceutical Group
Collagenex Pharmaceuticals
Columbia Presbyterian Medical Center
Columbia Research Laboratories
Commissie Voor Klinisch Toegepast Onderzoek
Community Research Initiative Of New England
Comprehensive Cancer Center Of Wake Forest University
Control Delivery Systems
Cooperative International Neuromuscular Research Group
Copharos
Corgentech
Corixa Corporation
Cornell University Medical College
Cortex Pharmaceuticals
Cosmo Bioscience
Ctl Immunotherapies Corporation
Cubist Pharmaceuticals
Cytokine Pharmasciences
Cytokine Working Group
Cytran


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103